Drug Topics

JANUARY 3, 2025

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Vaccines 185

Vaccines Immunization 185

Pharmacy Times

JANUARY 3, 2025

New medications like GLP-1 agonists and resmiterone show promise in reversing fatty liver disease and preventing progression.

122

122

pharmaphorum

JANUARY 3, 2025

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satri-cel has shown efficacy in gastric cancer, setting up a filing in China.

105

105

Pharmacy Times

JANUARY 3, 2025

Compliance is achievable for outpatient oncology practices with careful planning and execution.

122

122

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

JANUARY 3, 2025

Capricor completes its US filing for deramiocel, vying to become the first FDA-approved therapy for cardiomyopathy in Duchenne muscular dystrophy.

FDA 105

FDA 105

Pharmacy Times

JANUARY 3, 2025

Pharmacists should be aware of the impacts that anemia in patients being treated for cancer has on daily activities and overall quality of life.

117

117

Drug Topics

JANUARY 3, 2025

A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.

98

98

Fierce Healthcare

JANUARY 3, 2025

Mimicking prior federal and state investigations into drug manufacturers, health insurer Aetna is suing in Connecticut for rigging the generic drug market.

Insurance 98

Insurance 98

Drug Topics

JANUARY 3, 2025

Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.

Vaccines 98

Vaccines 98

pharmaphorum

JANUARY 3, 2025

Regeneron has bought Oxular, a UK specialist in retinal diseases, in a move that bolsters its already strong position in ophthalmology therapies.

90

90

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JANUARY 3, 2025

However, the effects on patient-reported outcomes were inconclusive when compared with self-monitoring blood glucose or the usual care.

89

89

pharmaphorum

JANUARY 3, 2025

Researchers have called for action to safeguard the independence of patient advocacy organisations as they increasingly rely on corporate funding.

75

75

Fierce Healthcare

JANUARY 3, 2025

Ardent Health is making good on its ambitions to grow its footprint in ambulatory care through acquisitions. The for-profit system kicked off 2025 by buying 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care.

69

69

STAT

JANUARY 3, 2025

Life was getting better for Carlos Campos, 72, a retired machinist who lives with his wife and daughter in Tukwila, Wash. Diagnosed about 20 years ago with type 2 diabetes, he was delighted to see his blood sugar levels improve dramatically about a year ago, when he started taking Ozempic.  Every week, in hour-long appointments, he shared his improved numbers via his continuous glucose monitor’s app with Maureen Chomko, a diabetes educator who works with his primary care physician at

102

102

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JANUARY 3, 2025

Patients with hormone receptorpositive and human epidermal growth factor receptor 2 breast cancer are particularly at risk.

65

65

Pharmaceutical Technology

JANUARY 3, 2025

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel

64

64

PharmaVoice

JANUARY 3, 2025

Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.

64

64

Pharmafile

JANUARY 3, 2025

HUTCHMED have announced that the China National Medical Products Administration (NMPA) have granted a priority review for a new drug application (NDA). The NDA will cover the combination of TAGRISSO (osimertinib) and ORPATHYS (savolitinib) in the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer […] The post NDA in China receives priority review status for lung cancer treatment appeared first

64

64

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

European Pharmaceutical Review

JANUARY 3, 2025

Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its

52

52

Pharmaceutical Technology

JANUARY 3, 2025

Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses and clinical trials.

59

59

Pharmaceutical Commerce

JANUARY 3, 2025

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

59

59

Pharmaceutical Technology

JANUARY 3, 2025

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

59

59

Pharmaceutical Commerce

JANUARY 3, 2025

The latest news for pharma industry insiders.

59

59

Pharmaceutical Technology

JANUARY 3, 2025

There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

59

59

Fierce Healthcare

JANUARY 3, 2025

Providence is no longer in-network for Oregonians enrolled in Aetna plans amid lengthy contract negotiations between the two. | Providence is no longer in-network for Oregonians enrolled in Aetna plans amid lengthy contract negotiations between the two.

55

55

Pharmaceutical Technology

JANUARY 3, 2025

China NMPA has granted acceptance and priority review for the NDA for HUTCHMEDs ORPATHYS (savolitinib) and TAGRISSO (osimertinib) combination

59

59

The Checkup by Singlecare

JANUARY 3, 2025

Gardasil 9 is a vaccine approved by the Food and Drug Administration (FDA) to prevent various medical conditions caused by nine types of human papillomavirus (HPV). According to the Centers for Disease Control and Prevention (CDC), HPV is one of the most common sexually transmitted infections (STIs) that causes genital warts and certain types of cancer, such as cervical cancer, anal cancer, vulvar cancer, throat (oropharyngeal) cancer, and penile cancers that develop from high-risk HPV strains.

Insurance 52

Insurance Vaccines Insurance Coverage FDA 52

Compounding Pharmacy of America

JANUARY 3, 2025

Discover how custom pet medication can address your furry friend's unique health needs. Learn about veterinary compounding and personalized care solutions. The post Custom Pet Medication: Tailored Solutions for Your Pet’s Health appeared first on Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

The Checkup by Singlecare

JANUARY 3, 2025

Got heartburn? Then youve probably taken your share of Tums and Rolaids. If you deal with chronic gastroesophageal reflux disease ( GERD ), you might also take a prescription drug for your condition. These medications work very differently in the body, which might make you wonder: Which is better for fast relief? Is it safe to take both? Tums is an over-the-counter (OTC), brand-name antacid.

Dosage 52

Dosage Adverse Reactions Insurance Labelling 52

Compounding Pharmacy of America

JANUARY 3, 2025

Learn about allergy medicine for dogs, including compounded solutions that address specific needs like skin irritations, food allergies, and environmental sensitivities. The post Everything You Need to Know About Allergy Medicine for Dogs appeared first on Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

PharmExec

JANUARY 3, 2025

PCV21 is the first pneumococcal conjugate vaccine candidate with more than 20 serotypes to enter a Phase III clinical trial in infants and toddlers.

Vaccines 52

Vaccines 52

pharmaphorum

JANUARY 3, 2025

As biotech start-ups evolve, the ability to communicate effectively with key stakeholders those who will fund the next stage of your journey becomes crucial.

Communication 52

Communication 52

PharmExec

JANUARY 3, 2025

Under terms of the deal, Johnson & Johnson will gain an exclusive license to the STAT6 program, with Kaken maintaining commercialization rights in Japan.

52

52